Skip to main content
SRES 532 112th Congress Senate Health Drug therapy HIV/AIDS Health care coverage and access Health promotion and preventive care Human rights International organizations and cooperation Medical research Medical tests and diagnostic methods Sex and reproductive health Women's health World health

A resolution expressing support for the XIX International AIDS Conference and the sense of the Senate that continued commitment by the United States to HIV/AIDS research, prevention, and treatment programs is crucial to protecting global health.

Introduced: July 26, 2012 See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 26, 2012
Passed/agreed to in Senate: Submitted in the Senate, considered, and passed without amendment and with a preamble by Voice Vote.(consideration: CR S5627; text as passed Senate: CR S5627; text of measure as introduced: CR S5494)
Jul 26, 2012
Submitted in the Senate, considered, and passed without amendment and with a preamble by Voice Vote. (consideration: CR S5627; text as passed Senate: CR S5627; text of measure as introduced: CR S5494)
Jul 26, 2012
Introduced in Senate
 Plain-English summary Congressional Research Service

(This measure has not been amended since it was introduced. The summary of that version is repeated here.)

Supports the XIX International AIDS Conference and the goal of renewing awareness of, and commitment to, addressing the HIV/AIDS crisis in the United States and abroad.

Recognizes that continued HIV/AIDS research, prevention, and treatment programs are crucial to improving global health.

Understands that the key to overcoming HIV/AIDS includes efforts to formulate sound public health policy, protect human rights, address the needs of women and girls, direct programming toward the populations at the highest risk of infection, and combat social challenges related to HIV/AIDS.

Encourages the ongoing development in the public and private sectors of innovative therapies and advances in clinical HIV/AIDS treatment.

What's happening now July 26, 2012

Submitted in the Senate, considered, and passed without amendment and with a preamble by Voice Vote. (consideration: CR S5627; text as passed Senate: CR S5627; text of measure as introduced: CR S5494)

 Cosponsors 2
All 2 Democratic 2